Platelet Activating Factor

A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.

Also Known As:

1- Alkyl- 2- acetyl- sn- glycerophosphocholine; Platelet Aggregating Factor; Platelet Aggregation Enhancing Factor; Platelet-Activating Substance; Thrombocyte Aggregating Activity; 1 Alkyl 2 acetyl sn glycerophosphocholine; Aggregating Factor, Platelet; Factor, Platelet Activating; PAF Acether; Platelet Activating Substance; AGEPC; Acetyl Glyceryl Ether Phosphorylcholine; PAF-Acether; Phosphorylcholine, Acetyl Glyceryl Ether

Organic Chemicals: 140
- Amines: 4925
  - Quaternary Ammonium Compounds: 142
    - Trimethyl Ammonium Compounds: 1
      - Choline: 6406
        Platelet Activating Factor: 2998
  - Amino Alcohols: 20
    - Ethanolamines: 16
      - Choline: 6406
        Platelet Activating Factor: 2998
- Alcohols: 610
  - Amino Alcohols: 20
    - Ethanolamines: 16
      - Choline: 6406
        Platelet Activating Factor: 2998
- Onium Compounds
  - Quaternary Ammonium Compounds: 142
    - Choline: 6406
      - Platelet Activating Factor: 2998
Lipids: 118169
- Membrane Lipids: 1619
  - Phospholipids: 12091
    - Glycerophosphates: 122
      - Phosphatidic Acids: 366
        Glycerophospholipids: 751
        Phospholipid Ethers: 36
        Platelet Activating Factor: 2998
Biological Factors: 2560
- Blood Coagulation Factors: 5500
  - Platelet Activating Factor: 2998
- Inflammation Mediators: 1126
  - Autacoids: 278
    - Platelet Activating Factor: 2998

Joyce G Rohan Selected Research

Joyce G Rohan Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure